Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. TME Pharma N.V.
  6. Funds
  7. Fonds PositionnÚs
    ALTME   NL0015000YE1

TME PHARMA N.V.

(ALTME)
  Report
Real-time Euronext Paris  -  11:12:15 2023-01-31 am EST
1.133 EUR   -3.20%
01/23Tme Pharma Provides Clinical Update on the Gloria Expansion Arm Testing Nox-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma
CI
01/20Tme Pharma N : Half-yearly report on the liquidity contract with Invest Securities
PU
2022Tme Pharma N : announces convocation of an extraordinary general meeting of shareholders
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsFunds 



Copyright ę 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ôInformationö) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Chart TME PHARMA N.V.
Duration : Period :
TME Pharma N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Chart TME PHARMA N.V.
Duration : Period :
TME Pharma N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
TME PHARMA N.V.-3.77%2
MODERNA, INC.5.42%69 487
LONZA GROUP AG17.81%42 878
IQVIA HOLDINGS INC.10.44%42 029
ALNYLAM PHARMACEUTICALS, INC.-2.64%27 731
SEAGEN INC.8.93%25 989